Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

Annual Review of Physiology
Volker Vallon, Scott C Thomson

Abstract

Diabetes mellitus affects the kidney in stages. At the onset of diabetes mellitus, in a subset of diabetic patients the kidneys grow large, and glomerular filtration rate (GFR) becomes supranormal, which are risk factors for developing diabetic nephropathy later in life. This review outlines a pathophysiological concept that focuses on the tubular system to explain these changes. The concept includes the tubular hypothesis of glomerular filtration, which states that early tubular growth and sodium-glucose cotransport enhance proximal tubule reabsorption and make the GFR supranormal through the physiology of tubuloglomerular feedback. The diabetic milieu triggers early tubular cell proliferation, but the induction of TGF-β and cyclin-dependent kinase inhibitors causes a cell cycle arrest and a switch to tubular hypertrophy and a senescence-like phenotype. Although this growth phenotype explains unusual responses like the salt paradox of the early diabetic kidney, the activated molecular pathways may set the stage for tubulointerstitial injury and diabetic nephropathy.

References

Jun 1, 1991·The American Journal of Physiology·C A PollockM J Field
Apr 1, 1990·Kidney International·T P HannedoucheJ P Grünfeld
Jul 1, 1990·The Journal of Clinical Investigation·N Bank, H S Aynedjian
Sep 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·J C MbanyaR Wilkinson
Jan 1, 1987·The Journal of Diabetic Complications·K Seyer-Hansen
Apr 1, 1988·Kidney International·A M KumarA Spitzer
May 1, 1986·The American Journal of Physiology·A M Weinstein
Jan 1, 1987·The American Journal of Physiology·L L WoodsJ E Hall
Feb 1, 1983·The American Journal of Physiology·R C BlantzO W Peterson
Feb 1, 1994·The American Journal of Physiology·J H DominguezW T Garvey
Feb 1, 1993·The American Journal of Physiology·S B PedersenB Richelsen
May 1, 1997·Journal of the American Society of Nephrology : JASN·J A Miller
Jul 1, 1997·The Journal of Laboratory and Clinical Medicine·V VallonS C Thomson
Apr 29, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H J BaumgartlE Standl
Sep 15, 1998·Kidney International. Supplement·S C ThomsonR C Blantz
Jul 15, 1999·Journal of the American Society of Nephrology : JASN·L A SlomowitzS C Thomson
Jul 20, 1999·Kidney International·S G JonesA O Phillips
Aug 5, 1999·Kidney International·G Wolf, F N Ziyadeh
Sep 7, 1999·Journal of the American Society of Nephrology : JASN·I L PfaffV Vallon
Dec 10, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·S C JonesC A Pollock
Dec 10, 1999·Journal of the American Society of Nephrology : JASN·V VallonH Osswald
Apr 6, 2000·American Journal of Physiology. Renal Physiology·D C HanF N Ziyadeh
Apr 28, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·B L JohanssonJ Wahren
Sep 20, 2001·Journal of the American Society of Nephrology : JASN·Volker VallonRichard Warth
Sep 29, 2001·Kidney International·B SamnegårdM Sjöquist
Jul 10, 2002·Current Opinion in Nephrology and Hypertension·Harold A Franch
Jan 23, 2003·Journal of the American Society of Nephrology : JASN·Volker VallonScott Thomson
Mar 14, 2003·Pflügers Archiv : European journal of physiology·Hamdy M EmbarkFlorian Lang

❮ Previous
Next ❯

Citations

Apr 9, 2013·Journal of Physiology and Biochemistry·Anela NovakAnita Markotić
Oct 9, 2013·Nature Reviews. Endocrinology·Daniel FinebergMark E Cooper
Jun 27, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sydney C W Tang, Kar Neng Lai
May 28, 2013·BioMed Research International·José L ReyesMaría Del Carmen Namorado
Jan 1, 2014·Nature Reviews. Nephrology·Marcel H A MuskietMichaela Diamant
Nov 17, 2012·Biochimica Et Biophysica Acta·K M HannanR B Pearson
Oct 30, 2015·Expert Opinion on Drug Safety·André J Scheen
Apr 22, 2014·Expert Opinion on Investigational Drugs·Elizabeth M LamosStephen N Davis
May 2, 2014·Advances in Chronic Kidney Disease·Roland C Blantz, Prabhleen Singh
Sep 29, 2015·Clinical and Experimental Pharmacology & Physiology·Dania YaghobianCarol Pollock
Nov 24, 2012·Molecular and Cellular Endocrinology·Chi-Hsien ChouJinn-Yuh Guh
Nov 10, 2015·Biochemical and Biophysical Research Communications·Ling ZhouXia Yin
Jan 1, 2015·Nature Reviews. Disease Primers·Merlin C ThomasMark E Cooper
Mar 29, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luca De NicolaRoberto Minutolo
Jun 15, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Irene ZubiriGloria Alvarez-Llamas
Feb 11, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·M ŠkrtićD Z I Cherney
Jun 30, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rania NasrallahRichard L Hébert
Mar 22, 2016·Expert Opinion on Therapeutic Targets·Panai SongVolker Vallon
Jul 7, 2012·European Journal of Pharmacology·Rajendra K KothintiNiloofar M Tabatabai
Sep 12, 2012·Clinical Science·Usha PanchapakesanCarol Pollock
May 29, 2015·International Urology and Nephrology·M PappaK Katopodis
Mar 15, 2015·Mathematical Biosciences·Ioannis Sgouralis, Anita T Layton
Feb 24, 2015·The Journal of Nutritional Biochemistry·Eduardo Molina-JijónJosé L Reyes
Sep 17, 2013·Cell Metabolism·Adrian Kee Keong TeoRohit N Kulkarni
May 14, 2016·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Lotte B BertelsenChristoffer Laustsen
Oct 23, 2014·PloS One·Jean-Christophe OrbanCarole Ichai
Dec 28, 2007·PLoS Genetics·Nicolas Di-PoïDenis Duboule
Aug 16, 2016·Journal of Diabetes Research·Alejandra Guillermina Miranda-DíazJorge Andrade-Sierra
Aug 20, 2016·Current Diabetes Reports·André J Scheen

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collections
acetylation

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Current Opinion in Nephrology and Hypertension
Charles E Alpers, Kelly L Hudkins
The New England Journal of Medicine
Mark I McCarthy
Heart Failure Clinics
Ravi Dhingra, Ramachandran S Vasan
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Scott C ThomsonPrabhleen Singh
© 2022 Meta ULC. All rights reserved